From: VIP Regulates the Development & Proliferation of Treg in vivo in spleen
Group 1: Controls (n = 10) | Group 2: VIP KO (n = 5) | Group 3: VIP KO + VIP (n = 5) | p-values for Group Comparisons | ||||||
---|---|---|---|---|---|---|---|---|---|
Median | Min, Max | Median | Min, Max | Median | Min, Max | 1 vs. 2 | 1 vs. 3 | 2 vs. 3 | |
CD4-CD25+ | 1146 | 666, 1831 | 3298 | 2953, 3517 | 3182 | 2579, 4109 | 0.0022* | 0.0022* | 0.47 |
CD4-CD25+Helios+ | 308 | 110, 436 | 2690 | 2520, 2966 | 1558 | 450, 1783 | 0.0022* | 0.0022* | 0.0091* |
CD4-CD25+FoxP3+Helios+ | 3 | 0, 22 | 11 | 2, 15 | 43 | 21, 1771 | 0.18 | 0.0031* | 0.0091* |
CD4+CD25+ (Treg) | 159 | 56, 563 | 204 | 177, 281 | 432 | 377, 596 | 0.63 | 0.015* | 0.0091* |
CD4+CD25+FoxP3+Helios- (Treg induced intrasplenically) | 44 | 0, 493 | 25 | 15, 58 | 48 | 25, 493 | 0.81 | 0.63 | 0.12 |
CD4+CD25+FoxP3-Helios+ (Treg) | 46 | 4, 79 | 141 | 111, 166 | 141 | 23, 171 | 0.0022* | 0.028 | 0.92 |
CD4+CD25+FoxP3+Helios+ (Treg) | 21 | 0, 423 | 25 | 15, 53 | 31 | 16, 378 | 0.81 | 0.40 | 0.26 |